Feature | Ellen W. Rothschild, RN, MS
There is considerable interest in being able to clearly identify vulnerable plaque (VP) and research efforts are intensifying. Several invasive imaging technologies claim to detect VP, and while the link between VP identification, plaque rupture and clinical events has yet to be firmly established, progress is being made in the research.
October 30, 2008
Technology
GE Healthcare’s recently released Vivid E9 ultrasound features Accelerated Volume Architecture (AVA), which not only makes single beat acquisition possible but, working alongside Extended Signal transducer technology in each probe, it reportedly delivers a leap in 2D, 4D and shared service image quality across the entire patient population.
October 30, 2008Technology
Micrus Endovascular Corp. initiated its worldwide launch of Neuropath guide catheter line, designed with a highly flexible and visible tip so neurointerventionalists can gain better vessel access and greater vessel selection in treating patients with complex anatomies.
October 30, 2008Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026
Technology
CardioECG 3.2, introduced by LUMEDX Corp. and Epiphany Cardiography Products, is a multimodality, multivendor, pure-Web ...
October 30, 2008
Technology
The nSPEED reconstruction software from Digirad Corp. is for use in its imaging systems for SPECT procedures at either half-time and/or half count densities with parallel and nonparallel hole collimators, reportedly resulting in quicker exams, improved image quality and less radiation exposure.
October 30, 2008Technology
The FDA granted approval for Covidien’s generic kit for the preparation of technetium Tc99m Sestamibi injection use for nuclear myocardial perfusion imaging.
October 30, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025Technology
Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC launched a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disease.
October 30, 2008News
October 31, 2008 - Surface modification and drug delivery technologies company SurModics Inc. said today it is providing ...
October 30, 2008
Feature | Nick Obradovich
"Potential” can be a loaded word, especially in healthcare. Many clinicians have tagged coronary MR angiography (MRA) with the “potential” label. Despite the scan’s reported safety advantages over coronary CT angiography (CTA), as well as its superior physiologic information, coronary MRA has not gained the widespread acceptance of coronary CTA.
October 30, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
October 29, 2008 - Nearly 18 months of data from Cappella’s Sideguard I and II self-expanding side branch heart stent in ...
October 29, 2008News
October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting ...
October 29, 2008
Feature | Dave Fornell
There have been numerous new products released in the past year to enhance implantable pacing and defibrillation devices, but new advances in remote monitoring seem to be paving the way of the future.
October 29, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
October 30, 2008 - CHF Solutions said seven studies supporting ultrafiltration therapy’s effectiveness and benefits in ...
October 29, 2008News
October 30, 2008 - Thinking Systems is debuting at RSNA 2008 its new release of the company’s unified Web-based ThinkingPACS/ThinkingRIS with comprehensive solutions for radiology, cardiology and molecular imaging.
October 29, 2008News
October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent Graft with an optimized delivery system.
October 29, 2008